首页> 美国卫生研究院文献>British Journal of Cancer >A triplet combination with irinotecan (CPT-11) oxaliplatin (LOHP) continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt metastatic colorectal cancer: a pilot phase II trial

【2h】

A triplet combination with irinotecan (CPT-11) oxaliplatin (LOHP) continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt metastatic colorectal cancer: a pilot phase II trial

机译：三联体联合伊立替康（CPT-11）奥沙利铂（LOHP）连续输注5-氟尿嘧啶和亚叶酸（FOLFOXIRI）加西妥昔单抗作为KRAS转移转移性结直肠癌的一线治疗：一项中试II期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: We conducted an open-label, pilot phase II trial to evaluate the efficacy and safety of FOLFOXIRI plus cetuximab as first-line treatment of patients with metastatic colorectal cancer (mCRC).

机译：背景：我们进行了一项开放标签的II期试验，以评估FOLFOXIRI加西妥昔单抗作为转移性结直肠癌（mCRC）患者一线治疗的疗效和安全性。

著录项

期刊名称 British Journal of Cancer
作者
Z Saridaki; N Androulakis; N Vardakis; L Vamvakas; E Kabouraki; K Kalbakis; D Hatzidaki; A Voutsina; D Mavroudis; V Georgoulias; J Souglakos;
展开▼
作者单位

展开▼
年(卷),期 2012(107),12
年度 2012
页码 1932–1937
总页数 6
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
FOLFOXIRI cetuximab metastatic colorectal cancer;

机译：FOLFOXIRI;西妥昔单抗;转移性结直肠癌;

相似文献

外文文献
中文文献
专利

1. CMAB009联合伊立替康或伊立替康单药二线治疗氟嘧啶和奥沙利铂治疗失败的KRAS野生型转移性结直肠癌患者的研究:一项前瞻性、开放、随机、Ⅲ期试验 [J] . 石远凯, 白丽, 张沂平, 癌症（英文版） . 2020,第007期
2. A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial [J] . Z Saridaki, N Androulakis, N Vardakis, British Journal of Cancer . 2012,第12期

机译：三联体联合伊立替康（CPT-11），奥沙利铂（LOHP），连续输注5-氟尿嘧啶和亚叶酸（FOLFOXIRI）加西妥昔单抗作为KRAS转移，转移性结直肠癌的一线治疗：一项中试II期临床试验
3. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologic [J] . Falcone A, Ricci S, Brunetti I, Journal of Clinical Oncology . 2007,第13期

机译：输注氟尿嘧啶，亚叶酸钙，奥沙利铂和伊立替康（FOLFOXIRI）与输注氟尿嘧啶，亚叶酸钙和伊立替康（FOLFIRI）作为转移性结直肠癌的一线治疗的三期试验：Gruppo肿瘤学
4. Triplet Combination With Irinotecan Plus Oxaliplatin Plus Continuous-Infusion Fluorouracil and Leucovorin as First-Line Treatment in Metastatic Colorectal Cancer: A Multicenter Phase II Trial. [J] . Souglakos J, Mavroudis D, Kakolyris S, Journal of Clinical Oncology . 2002,第11期

机译：三联体联合伊立替康加奥沙利铂加连续输注氟尿嘧啶和白细胞素作为转移性结直肠癌的一线治疗：多中心II期试验。
5. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
6. FOLFOXIRI (folinic acid 5-fluorouracil oxaliplatin and irinotecan) vs FOLFIRI (folinic acid 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG) [O] . J Souglakos, N Androulakis, K Syrigos, 2006

机译：FOLFOXIRI（亚叶酸5-氟尿嘧啶奥沙利铂和伊立替康）与FOLFIRI（亚叶酸5-氟尿嘧啶和伊立替康）作为转移性结直肠癌（MCC）的一线治疗：来自希腊肿瘤研究组的多中心随机III期试验（霍格）
7. A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial [O] . Z Saridaki, N Androulakis, N Vardakis, 2012

机译：与Irinotecan（CPT-11），Oxaliplatin（LoHP），连续输注5-氟尿嘧啶和白草（Folfoxiri）加上西妥昔单抗作为克拉斯直肠直肠癌的一线治疗，转移结直肠癌：试验期II试验

A triplet combination with irinotecan (CPT-11) oxaliplatin (LOHP) continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt metastatic colorectal cancer: a pilot phase II trial

摘要

著录项

相似文献

相关主题

期刊订阅